Front. Pharmacol.
Frontiers in Pharmacology
Front. Pharmacol.
1663-9812
Frontiers Media S.A.
1264737
10.3389/fphar.2023.1264737
Pharmacology
Correction
Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)
Frontiers Editorial Office
10.3389/fphar.2023.1264737
Frontiers Editorial Office
*
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org
31
07
2023
2023
14
1264737
21
07
2023
21
07
2023
Copyright © 2023 Frontiers Editorial Office.
2023
Frontiers Editorial Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Expression of concern on: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma) by Agrawal S, Vamadevan P, Mazibuko N, Bannister R, Swery R, Wilson S and Edwards S (2019). Front. Pharmacol. 10:681. doi: 10.3389/fphar.2019.00681
section-at-acceptance
Experimental Pharmacology and Drug Discovery
With this notice, Frontiers states its awareness of concerns regarding the METRICS study described in this article. This expression of concern has been posted while Frontiers investigates the allegations. The situation will be updated as soon as the investigation is complete.